A shocking revelation has emerged from a recent study: despite medical guidelines, many older adults with dementia are still being prescribed medications that could significantly harm them. But here's the catch: these drugs are known to cause falls, confusion, and even hospitalization.
The research, soon to be published in JAMA, reveals a concerning trend. While the overall prescription rate for these medications has decreased among Medicare beneficiaries, the numbers are still alarming for those with dementia. One in four patients with dementia are being prescribed these brain-altering drugs.
And this is the part most people miss: the study found that over two-thirds of these prescriptions lacked a documented clinical reason in 2021. This suggests a worrying trend of potentially harmful and unnecessary medication use.
The study focused on five classes of central nervous system (CNS) medications: strong anticholinergic antidepressants, antipsychotics, barbiturates, benzodiazepines, and non-benzodiazepine hypnotics. These drugs were prescribed to older adults with normal cognition, cognitive impairment without dementia, and dementia.
Interestingly, CNS medication prescription rates were higher for those with cognitive issues. Nearly 22% of older adults with cognitive impairment but no dementia were prescribed these drugs, compared to 17% of those with normal cognition. The rate was even higher, at 25%, for those with dementia.
The study also revealed a mixed bag of prescription trends. While benzodiazepines and sleep medications decreased, antipsychotic prescriptions increased. Anticholinergic antidepressant prescriptions remained stable, and barbiturate prescriptions saw a slight decline.
The researchers noted that the improvement in prescription trends was primarily due to reduced benzodiazepine and sleep medication prescriptions, as well as a decrease in inappropriate prescriptions. However, they also acknowledged limitations, including missing clinical data and a focus on prescription prevalence rather than long-term exposure.
Dr. Annie Yang, the lead researcher, emphasized the importance of careful consideration when prescribing CNS medications to older patients. She suggests that patients and caregivers work closely with physicians to ensure the appropriateness of these medications and explore alternative treatments when necessary.
This study raises crucial questions about the care of older adults with dementia. Are we doing enough to protect this vulnerable population from potentially harmful medications? What steps can be taken to ensure more cautious and informed prescribing practices? Share your thoughts in the comments, and let's continue this important conversation.
